<DOC>
	<DOCNO>NCT01556334</DOCNO>
	<brief_summary>Preterm Premature Rupture Membranes ( PPROM ) treat antibiotic , erythromycin azithromycin , prolong pregnancy . Erythromycin take several day result stomach upset patient , cause stop take medication . Therefore , azithromycin often prescribe instead . Azithromycin usually take stomach upset see greatly reduce . The goal study see difference antibiotic ( azithromycin ) compare antibiotic ( erythromycin ) prolong pregnancy patient Preterm Premature Rupture Membranes ( PPROM ) . The work hypothesis difference clinical effectiveness antibiotic regimen contain macrolides azithromycin erythromycin prolong latency PPROM .</brief_summary>
	<brief_title>Erythromycin Versus Azithromycin Preterm Premature Rupture Membranes</brief_title>
	<detailed_description>Preterm , premature rupture membrane complicate 140,000 pregnancy annually United States major contributor pre-term birth resultant neonatal morbidity mortality . Typically , brief period latency exist PPROM , 70-80 % woman deliver within 1st week membrane rupture . It show numerous well-conducted trial antibiotic prolong latency time delivery . Mercer et al. , demonstrate administration ampicillin erythromycin prolonged median time delivery , comparison placebo , 2.9 6.1 day . This regimen become standard protocol treatment PPROM patient . However , protocol require multi-day dose regimen erythromycin know untoward gastrointestinal side effect lead decreased patient compliance . To overcome challenge , azithromycin , new 2nd generation macrolide , commonly use substitution many labor delivery unit nationwide . Azithromycin long intracellular half-life , allow patient friendly one-time dose regimen ; addition many unwanted side effect see erythromycin see greatly reduced azithromycin , make attractive alternative . Despite popular use , lack evidence literature support azithromycin agent prolong latency . The purpose study demonstrate difference clinical effectiveness azithromycin erythromycin prolong latency PPROM patient . This trial prospective randomize trial perform singleton pregnancy PPROM 24 0/7 - 32 0/7 week gestation . The protocol enroll 250 eligible woman randomize receive either azithromycin 1 gm orally enrollment erythromycin 250mg IV every 6 hour 48 hour follow 500mg orally every 8hours 5 day . All woman also receive standard ampicillin 2gm IV every 6 hour follow amoxicillin 250mg orally every 8 hour 5 day . The primary outcome measure time latency two group . Secondary outcome neonatal death , need oxygen supplementation , ventilation , neonatal infection , also review . In addition , side effect profile two assessed post treatment patient survey .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Rupture</mesh_term>
	<mesh_term>Fetal Membranes , Premature Rupture</mesh_term>
	<mesh_term>Erythromycin</mesh_term>
	<mesh_term>Erythromycin Estolate</mesh_term>
	<mesh_term>Erythromycin Ethylsuccinate</mesh_term>
	<mesh_term>Erythromycin stearate</mesh_term>
	<criteria>Pregnant woman least 18 year old Gestational age 24 0/7 32 0/7 week Singleton gestation Randomization within 36 hour rupture membrane . Cervical dilation less equal 4 cm . Known lethal fetal anomaly Vaginal bleeding associate labor Maternal fetal indication delivery Diagnosis chorioamnionitis admission Cervical cerclage place Placenta previa know placental anomaly Use antibiotic therapy within 5 day . Allergy contraindication erythromycin/azithromycin steroid use .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>premature rupture membrane</keyword>
	<keyword>azithromycin</keyword>
	<keyword>erythromycin</keyword>
	<keyword>latency</keyword>
	<keyword>antibiotic</keyword>
</DOC>